Vaccination concepts against Toxoplasma gondii

References

• Frenkel JK. Transmission of toxoplasmosis and the role of immunity in limiting transmission and illness. J. Am. Vet. Med. Assoc.196(2), 233–240 (1990).
   PubMed Web of Science ®Google Scholar
• Frenkel JK, Smith DD. Inhibitory effects of monesin on shedding of Toxoplasma oocysts by cats. J. Parasitol.68, 851–855 (1982).
   PubMed Web of Science ®Google Scholar
• Dubey JP, Navarro IT, Sreekumar C et al.Toxoplasma gondii infections in cats from Paraná, Brazil: seroprevalence, tissue distribution, and biologic and genetic characterization of isolates. J. Parasitol.90, 721–726 (2004).
   PubMed Web of Science ®Google Scholar
• Garcia JL, Navarro IT, Ogawa L, Kobilka F. Seroprevalence, epidemiology, and ocular evaluation of human toxoplasmosis in a rural area in Jaguapitã, Paraná, Brazil. Pan. Am. Public Health6, 157–163 (1999).
   PubMedGoogle Scholar
• Navarro IT, Vidotto O, Giraldi N, Freire RL. Toxoplasma gondii: isolamento a partir de carne e cérebro de suínos comercializados na região de Londrina, Pr. Semina13, 15–18 (1992).
   Google Scholar
• Roberts T, Frenkel JK. Estimation income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. J. Am. Vet. Med. Assoc.196(2), 249–256 (1990).
   PubMed Web of Science ®Google Scholar
• Camargo Neto E, Anele E, Rubin R et al. High prevalence of congenital toxoplasmosis in Brazil estimated in a 3-year prospective neonatal screening study. Int. J. Epidemiol.29, 941–947 (2000).
   PubMed Web of Science ®Google Scholar
• Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H, Petersen E. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999–2002. Arch. Dis. Child.91(8), 661–665 (2006).
   PubMed Web of Science ®Google Scholar
• Leport C, Franck J, Chene G et al. Immunoblot profile as predictor of toxoplasmic encephalitis in patients infected with human immunodeficiency virus. Clin. Diagn. Lab. Immunol.8(3), 579–584 (2001).
   PubMedGoogle Scholar
• Luft BJ, Hafner R, Korzun AH et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med.329(14), 995–1000. (1993).
   PubMed Web of Science ®Google Scholar
• Schetters T. Vaccine development from a commercial point of view. Vet. Parasitol.57(1–3), 267–275 (1995).
   PubMed Web of Science ®Google Scholar
• Frenkel JK, Dubey JP, Miller NL. Toxoplasma gondii in cats: fecal stages identified as coccidian oocysts. Science167, 893–896 (1970).
   PubMed Web of Science ®Google Scholar
• Miller N L, Frenkel JK, Dubey JP. Oral infections with Toxoplasma cysts and oocysts in felines, other mammals and birds. J. Parasitol.58, 928–937 (1972).
   PubMed Web of Science ®Google Scholar
• Innes EA. Toxoplasmosis: comparative species susceptibility and host immune response. Comp. Immunol. Microbiol. Infect. Dis.20(2), 131–138 (1997).
   PubMed Web of Science ®Google Scholar
• Dubey JP. Toxoplasma, Neospora, Sarcocystis and other tissue cyst-forming of human and animals. In: Parasitic Protozoa. Krier JP (Ed.). Academic Press, CA, USA 1–157 (1993).
   Google Scholar
• Sethi KK, Piekarski G. Immunological aspects of toxoplasmosis. In: Immune Responses in Parasitic Infectious: Immunology; Immunopathology and Immunoprophylaxis (Volume 3). Soulsby EJL (Ed.). CRC Press, FL, USA (1987).
   Google Scholar
• Nichols BA, Chiappino ML. Cytoskeleton of Toxoplasma gondii. J. Parasitol.34(2), 217–226 (1987).
   Google Scholar
• Bouchot A, Zierold K, Bonhomme A et al. Tachyzoite calcium changes during cell invasion by Toxoplasma gondii. Parasitol. Res.85, 809–818 (1999).
   PubMed Web of Science ®Google Scholar
• Pacheco-Soares C, Souza W. Labeled probes inserted in the macrophage membrane are transferred to the parasite surface and internalized during cell invasion by Toxoplasma gondii. Parasitol. Res.86(1), 11–17 (2000).
   PubMed Web of Science ®Google Scholar
• Hoff EF, Carruthers VB. Is Toxoplasma egress the first step in invasion? Trends Parasitol.18(6), 251–255 (2002).
   PubMed Web of Science ®Google Scholar
• Kimata I, Tanabe K. Secretion by Toxoplasma gondii of an antigen that appears to become associated with the parasitophorous vacuole membrane upon invasion of the host cell. J. Cell Sci.88, 231–239 (1997).
   Google Scholar
• Sadak A, Taghy Z, Fortier B, Dubrementz JF. Characterization of a family of rhoptry proteins of Toxoplasma gondii. Mol. Bioch. Parasitol.29, 203–212 (1988).
   PubMed Web of Science ®Google Scholar
• Coppens I, Andries M, Liu JL, Cesbron-Delauw MF. Intracellular trafficking of dense granule proteins in Toxoplasma gondii and experimental evidences for a regulated exocytosis. Eur. J. Cell Biol.78, 463–472 (1999).
   PubMed Web of Science ®Google Scholar
• Howe DK, Sibley LD. Toxoplasma gondii: analysis of different laboratory stocks of the RH strain reveals genetic heterogeneity. Exp. Parasitol.78(2), 242–245 (1994).
   PubMed Web of Science ®Google Scholar
• Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis.15(2), 211–222 (1992).
   PubMed Web of Science ®Google Scholar
• Dubey JP. Toxoplasmosis. J. Am. Vet. Med. Assoc.205(11), 1593–1598 (1994).
   PubMed Web of Science ®Google Scholar
• Dubey JP, Baker DG, Davis SW, Urban JF, Shen SK. Persistence of immunity to toxoplasmosis in pigs vaccinated with a nonpersitent strain of Toxoplasma gondii. Am. J. Vet. Res.55(7), 982–987 (1994).
   PubMed Web of Science ®Google Scholar
• Liesenfeld O, Nguyen TA, Pharke C, Suzuki Y. Importance of gender and sex hormones in regulation of susceptibility of the small intestine to peroral infection with Toxoplasma gondii tissue cysts. J. Parasitol.87(6), 1491–1493 (2001).
   PubMed Web of Science ®Google Scholar
• Dubey JP, Jones JL. Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol.38(11), 1257–1258 (2008).
   PubMed Web of Science ®Google Scholar
• Miller CM, Boulter NR, Ikin RJ, Smith NC. The immunobiology of the innate response to Toxoplasma gondii. Int. J. Parasitol.39(1), 23–39 (2008).
   PubMed Web of Science ®Google Scholar
• Buzoni-Gatel D, Kasper LH. Innate immunity in Toxoplasma gondii infection. In: Toxoplasma gondii: the Model Apicomplexan. Perspectives and Methods. Weiss L, Kim K (Eds). Academic press, London, UK 593–608 (2007).
   Google Scholar
• Roberts CW, Gazzinelli RT, Khan IA, Nowakowska D, Esquivel A, McLeod R. Adaptive immunity and genetics of the host immune response In: Toxoplasma gondii: the Model Apicomplexan. Perspectives and Methods. Weiss L, Kim K (Eds). Academic Press, London, UK 610–720 (2007).
   Google Scholar
• Sibley LD, Mordue DG, Su C, Robben PM, Howe DK. Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii. Philos. Trans. R. Soc. Lond. B Biol. Sci.357, 81–88 (2002).
   PubMed Web of Science ®Google Scholar
• Denkers EY, Butcher BA, Del Rio L, Bennouna S. Neutrophils, dendritic cells and Toxoplasma. Int. J. Parasitol.34(3), 411–421 (2004).
   PubMed Web of Science ®Google Scholar
• Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J. Immunol.149(1), 175–180 (1992).
   PubMed Web of Science ®Google Scholar
• Wastling JM, Harkins D, Maley S et al. Kinetics of the local and systemic antibody response to primary and secondary infection with S48 Toxoplasma gondii in sheep. J. Comp. Path.112, 53–62 (1995).
   PubMed Web of Science ®Google Scholar
• Alexander J, Hunter CA. Immunoregulating during toxoplasmosis. Chem. Immunol.70, 81–102 (1998).
   PubMedGoogle Scholar
• Jungi TW, Adler H, Adler B, Thoeny M, Krampe M, Peterhans E. Inducible nitric oxide synthase of macrophages: present knowledge and evidence of species specific regulation. Vet. Immunol. Immunopathol.54, 323–330 (1996).
   PubMed Web of Science ®Google Scholar
• Solano Aguilar GI, Beshah E, Vengroski KG et al. Cytokine and lymphocyte profiles in miniature swine after oral infection with Toxoplasma gondii oocysts. Int. J. Parasitol.31(2), 187–195 (2001).
   PubMed Web of Science ®Google Scholar
• Dawson HD, Beshah E, Nishi S et al. Localized multigene expression patterns support an evolving Th1/Th2-like paradigm in response to infections with Toxoplasma gondii and Ascaris suum. Infect. Immun.73(2), 1116–1128 (2005).
   PubMed Web of Science ®Google Scholar
• Innes EA, Panton WRM, Sanderson A et al. Induction of CD4+ and CD8+ T cell responses in efferent lymph responding to Toxoplasma gondii infection: analysis of phenotype and function. Parasite Immunol.17, 151–160 (1995).
   PubMed Web of Science ®Google Scholar
• Kalinna BH. DNA vaccines for parasitic infections. Immunol. Cell Biol.75(4), 370–375 (1997).
   PubMed Web of Science ®Google Scholar
• Babiuk LA. Vaccination: a management tool in veterinary medicine. Vet. J.164(3), 188–201 (2002).
   PubMed Web of Science ®Google Scholar
• Frenkel JK, Pfefferkorn ER, Smith DD, Fishback JL. Prospective vaccine prepared from a new mutant of Toxoplasma gondii for use in cats. Am. J. Vet. Res.52, 759–763 (1991).
   PubMed Web of Science ®Google Scholar
• Freyre A, Choromanski L, Fishback JL, Popiel I. Immunization of cats with tissue cysts, bradyzoites, and tachyzoites of the T-263 strain of Toxoplasma gondii. J. Parasitol.79(5), 716–719 (1993).
   PubMed Web of Science ®Google Scholar
• Mateus-Pinilla NE, Dubey JP, Choromanski L, Weigel RM. A field trial of the effectiveness of a feline Toxoplasma gondii vaccine in reducing T. gondii exposure for swine. J. Parasitol.85(5), 855–860 (1999).
   PubMed Web of Science ®Google Scholar
• Dubey JP. Duration of immunity to shedding of Toxoplasma gondii oocysts by cats. J. Parasitol.81(3), 410–415 (1995).
   PubMed Web of Science ®Google Scholar
• Omata Y, Aihara Y, Kanda M, Saito A, Igarashi I, Suzuki N. Toxoplasma gondii: experimental infection in cats vaccinated with 60Co-irradiated tachyzoites. Vet. Parasitol.65(3–4), 173–183 (1996).
   PubMed Web of Science ®Google Scholar
• Mishima M, Xuan X, Yokoyama N et al. Recombinant feline herpesvirus type 1 expressing Toxoplasma gondi ROP2 antigen inducible protective immunity in cats. Parasitol. Res.88(2), 144–149 (2002).
   PubMed Web of Science ®Google Scholar
• Garcia JL, Navarro IT, Biazzono L et al. Protective activity against oocyst shedding in cats vaccinated with crude rhoptry proteins of the Toxoplasma gondii by the intranasal route. Vet. Parasitol.145(3–4), 197–206 (2007).
   PubMed Web of Science ®Google Scholar
• Dubey JP, Urban JF Jr, Davis SW. Protective immunity to toxoplasmosis in pigs vaccinated with a nonpersistent strain of Toxoplasma gondii. Am. J. Vet. Res.52(8), 1316–1319 (1991).
   PubMed Web of Science ®Google Scholar
• Dubey JP, Lunney JK, Shen SK, Kwok OCH. Immunity to toxoplasmosis in pigs fed irradiated Toxoplasma gondii oocysts. J. Parasitol.84, 749–752 (1998).
   PubMed Web of Science ®Google Scholar
• Supply S, Sutton P, Coughlan SN et al. Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii. Vaccine17(7–8), 705–714 (1999).
   PubMed Web of Science ®Google Scholar
• Pinckney RD, Lindsay DS, Blagburn BL, Boosinger TR, Mclaughlin SA, Dubey JP. Evaluation of the safety and efficacy of vaccination of nursing pigs with living tachyzoites of two strains of Toxoplasma gondii. J. Parasitol.80(3), 438–448 (1994).
   PubMed Web of Science ®Google Scholar
• Garcia JL, Gennari SM, Navarro IT et al. Partial protection against tissue cysts formation in pigs vaccinated with crude rhoptry proteins of Toxoplasma gondii. Vet. Parasitol.129(3–4), 209–217 (2005).
   PubMed Web of Science ®Google Scholar
• Sabin AB. Toxoplasmosis encephalites in children. JAMA16, 801–807 (1941).
   Google Scholar
• Freire RL, Navarro IT, Bracarense APFRL, Gennari SM. Vaccination of pigs with Toxoplasma gondii antigens incorporated in immunostimulating complexes (ISCOMs). Arq. Bras. Med. Vet. Zootec.55(4), 388–396 (2003).
   Google Scholar
• Jongert E, Melkebeek V, De Craeye S, Dewit J, Verhelst D, Cox E. An enhanced GRA1-GRA7 cocktail DNA vaccine primes anti-Toxoplasma immune responses in pigs. Vaccine26(8), 1025–1031 (2008).
   PubMed Web of Science ®Google Scholar
• Dubey JP. Persistence of encysted Toxoplasma gondii in caprine livers and public health significance of toxoplasmosis in goats. J. Am. Vet. Med. Assoc.177(12), 1203–1207 (1980).
   PubMed Web of Science ®Google Scholar
• Buxton D. Protozoan infections (Toxoplasma gondii, Neospora caninum and Sarcocystis spp.) in sheep and goats: recent advances. Vet. Res.29(3–4), 289–310 (1998).
   PubMed Web of Science ®Google Scholar
• Dubey JP. Toxoplasma-induced abortion in dairy goats. J. Am. Vet. Med. Assoc.178, 671–674 (1981).
   PubMed Web of Science ®Google Scholar
• Chiari CA, Neves DP. Toxoplasmose humana adquirida através da ingestão de leite de cabra. Mem. Ins. Osv. Cruz79, 337–340 (1984).
   PubMedGoogle Scholar
• Vitor RWA, Pinto JB, Chiari CA. Clinical, parasitological and obstetric observations in pregnant bitches with experimental toxoplasmosis. Arq. Bras. Med. Vet. Zootec.43, 147–154 (1991).
   Google Scholar
• Innes EA, Bartley PM, Maley SW, Wright SE, Buxton D. Comparative host–parasite relationships in ovine toxoplasmosis and bovine neosporosis and strategies for vaccination. Vaccine25, 5495–5503 (2007).
   PubMed Web of Science ®Google Scholar
• Dubey JP. Protective immunity against clinical toxoplasmosis in dairy goats vaccinated with Hammondia hammondi and Hammondia heydorni. Am. J. Vet. Res.42(12), 2068–2070 (1981).
   PubMed Web of Science ®Google Scholar
• Dubey JP. Prevention of abortion and neonatal death due to toxoplasmosis by vaccination of goats with the nonpathogenic coccidium Hammondia hammondi. Am. J. Vet. Res.42(12), 2155–2157 (1981).
   PubMed Web of Science ®Google Scholar
• Wilkins MF, O’Connell E, Te Punga WA. Toxoplasmosis in sheep. I. Effect of a killed vaccine on lambing losses caused by experimental challenge with Toxoplasma gondii. NZ Vet. J.35(3), 31–34 (1987).
   PubMed Web of Science ®Google Scholar
• Wilkins MF, O’Connell E, Te Punga WA. Toxoplasmosis in sheep III. Further evaluation of the ability of a live Toxoplasma gondii vaccine to prevent lamb losses and reduce congenital infection following experimental oral challenge. NZ Vet. J.36(2), 86–89 (1988).
   PubMed Web of Science ®Google Scholar
• O’Connell E, Wilkins MF, Te Punga WA. Toxoplasmosis in sheep. II. The ability of a live vaccine to prevent lamb losses after an intravenous challenge with Toxoplasma gondii. NZ Vet. J.36(1), 1–4 (1988).
   PubMed Web of Science ®Google Scholar
• Buxton D, Uggla A, Lövgren K et al. Trial of a novel experimental Toxoplasma iscom vaccine in pregnant sheep. Br. Vet. J.145(5), 451–457 (1989).
   PubMedGoogle Scholar
• Buxton D, Thomson K, Maley S, Wright S, Bos HJ. Vaccination of sheep with a live incomplete strain (S48) of Toxoplasma gondii and their immunity to challenge when pregnant. Vet. Rec.129(5), 89–93 (1991).
   PubMed Web of Science ®Google Scholar
• Buxton D, Innes EA. A commercial vaccine for ovine toxoplasmosis. Parasitology110(Suppl.), S11–S16 (1995).
   PubMed Web of Science ®Google Scholar
• Bhopale GM. Development of a vaccine for toxoplasmosis: current status. Microbes Infect.5(5), 457–462 (2003).
   PubMed Web of Science ®Google Scholar
• Stanley AC, Buxton D, Innes EA, Huntley JF. Intranasal immunisation with Toxoplasma gondii tachyzoite antigen encapsulated into PLG microspheres induces humoral and cell-mediated immunity in sheep. Vaccine22(29–30), 3929–3941 (2004).
   PubMed Web of Science ®Google Scholar
• Williams DM, Grumet FC, Remington JS. Genetic control of murine resistance to Toxoplasma gondii. Infect. Immun.19(2), 416–420 (1978).
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Orellana MA, Wong SY, Conley FK, Remington JS. Susceptibility to chronic infection with Toxoplasma gondii does not correlate with susceptibility to acute infection in mice. Infect. Immun.61(6), 2284–2288 (1993).
   PubMed Web of Science ®Google Scholar
• Brown CR, Hunter CA, Estes RG et al. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. Immunology85(3), 419–428 (1995).
   PubMed Web of Science ®Google Scholar
• Roberts CW, Cruickshank SM, Alexander J. Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infect. Immun.63(7), 2549–2555 (1995).
   PubMed Web of Science ®Google Scholar
• Walker W, Roberts CW, Ferguson DJP, Jebbari H, Alexander J. Innate immunity to toxoplasma gondii is influenced by gender and is associated with differences in interleukin-12 and γ interferon production. Infect. Immun.65(3), 1119–1121, (1997).
   PubMed Web of Science ®Google Scholar
• Zenner L, Estaquier J, Darcy F, Maes P, Capron A, Cesbron-Delauw MF. Protective immunity in the rat model of congenital toxoplasmosis and the potential of excreted-secreted antigens as vaccine components. Parasite Immunol.21(5), 261–272 (1999).
   PubMed Web of Science ®Google Scholar
• Schaap D, Vermeulen AN, Roberts CW, Alexander J. Vaccination against toxoplasmosis: current status and future prospects. In: Toxoplasma gondii: the Model Apicomplexan. Perspectives and Methods. Weiss L, Kim K (Eds). Academic Press, London, UK 593–608 (2007).
   Google Scholar
• Roberts CW, Alexander J. Studies on a murine model of congenital toxoplasmosis: vertical disease transmission only occurs in BALB/c mice infected for the first time during pregnancy. Parasitology104, 19–23 (1992).
   PubMed Web of Science ®Google Scholar
• Freyre A, Falcón J, Mendez J, González M. Toxoplasma gondii: differential protection rates by two strains against cyst formation in a rat model. Exp. Parasitol.114(4), 265–270 (2006).
   PubMed Web of Science ®Google Scholar
• McLeod R, Frenkel JK, Estes RG, Mack DG, Eisenhauer PB, Gibori G. Subcutaneous and intestinal vaccination with tachyzoites of Toxoplasma gondii and acquisition of immunity to peroral and congenital toxoplasma challenge. J. Immunol.140(5), 1632–1637 (1988).
   PubMed Web of Science ®Google Scholar
• Roberts CW, Brewer JM, Alexander J. Congenital toxoplasmosis in the balb/c mouse: prevention of vertical disease transmission and fetal death by vaccination. Vaccine12(15), 1389–1394 (1994).
   PubMed Web of Science ®Google Scholar
• Velge-Roussel F, Marcelo P, Lepage AC, Buzoni-Gatel D, Bout DT. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments. Infect. Immun.68, 969–972 (2000).
   PubMed Web of Science ®Google Scholar
• Wu HY, Russel MW. Induction of a mucosal and systemic immune response by intranasal immunization using recombinant cholera toxin B subunit as adjuvant. Vaccine16, 286–292 (1998).
   PubMed Web of Science ®Google Scholar
• Freyre A, Falcón J, Méndez J, Rodriguez A, Correa L, Gonzalez M. Toxoplasma gondii: partial cross-protection among several strains of the parasite against congenital transmission in a rat model. Exp. Parasitol.112(1), 8–12 (2006).
   PubMed Web of Science ®Google Scholar
• Ferreira AM, Martins MS, Vitor RW. Virulence for BALB/c mice and antigenic diversity of eight Toxoplasma gondii strains isolated from animals and humans in Brazil. Parasite8(2), 99–105 (2001).
   PubMedGoogle Scholar
• Saeji JPJ, Boylle JP, Coller S et al. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science314, 1780–1783 (2006).
   PubMed Web of Science ®Google Scholar
• Taylor S, Barragan A, Su C et al. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science314, 1776–1780 (2006).
   PubMed Web of Science ®Google Scholar
• Bülow R, Boothroyd JC. Protection of mice from fatal Toxoplasma gondii infection by immunization with p30 antigen in liposomes. J. Immunol.147(10), 3496–3500 (1991).
   PubMed Web of Science ®Google Scholar
• Darcy F, Maes P, Gras-Masse H et al. Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii P30 antigen. J. Immunol.149(11), 3636–3641 (1992).
   PubMed Web of Science ®Google Scholar
• Bourguin I, Chardès T, Bout D. Oral immunization with Toxoplasma gondii antigens in association with cholera toxin induces enhanced protective and cell-mediated immunity in C57BL/6 mice. Infect. Immun.61(5), 2082–2088 (1993).
   PubMed Web of Science ®Google Scholar
• Debard N, Buzoni-Gatel D, Bout D. Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection. Infect. Immun.64(6), 2158–2166 (1996).
   PubMed Web of Science ®Google Scholar
• Dubey JP, Jenkins MC, Thayer DW, Kwok OC, Shen SK. Killing of Toxoplasma gondii oocysts by irradiation and protective immunity induced by vaccination with irradiated oocysts. J. Parasitol.82(5), 724–727 (1996).
   PubMed Web of Science ®Google Scholar
• Petersen E, Nielsen HV, Christiansen L, Spenter J. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine16(13), 1283–1289 (1998).
   PubMed Web of Science ®Google Scholar
• Vercammen M, Scorza T, Huygen K et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7, and ROP2 induces partially protective immunity against lethal challenge in mice. Infect. Immun.68(1), 38–45 (2000).
   PubMed Web of Science ®Google Scholar
• Desolme B, Mévélec MN, Buzoni-Gatel D, Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine18(23), 2512–2521 (2000).
   PubMed Web of Science ®Google Scholar
• Leyva R, Hérion P, Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol. Res.87(1), 70–79 (2001).
   PubMed Web of Science ®Google Scholar
• Bonenfant C, Dimier-Poisson I, Velge-Roussel F et al. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii. Infect. Immun.69(3), 1605–1612 (2001).
   PubMed Web of Science ®Google Scholar
• Daryani A, Hosseini AZ, Dalimi A. Immune responses against excreted/secreted antigens of Toxoplasma gondii tachyzoites in the murine model. Vet. Parasitol.113(2), 123–134 (2003).
   PubMed Web of Science ®Google Scholar
• Roque-Reséndiz JL, Rosales R, Herion P. MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis. Parasitology128(4), 397–405 (2004).
   PubMed Web of Science ®Google Scholar
• Martin V, Supanitsky A, Echeverria PC et al. Recombinant GRA4 or ROP2 protein combined with alum or the gra4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin. Diagn. Lab. Immunol.11(4), 704–710 (2004).
   PubMedGoogle Scholar
• Beghetto E, Nielsen HV, Del Porto P et al. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. J. Infect. Dis.191, 637–645 (2005).
   PubMed Web of Science ®Google Scholar
• Dimier-Poisson I, Aline F, Bout D, Mévélec MN. Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA. Vaccine24(10), 1705–1709 (2006).
   PubMed Web of Science ®Google Scholar
• Beauvillain C, Ruiz S, Guiton R, Bout D, Dimier-Poisson I. A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice. Microbes Infect.9(14–15), 1614–1622 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang H, Lee EG, Liao M et al. Identification of ribosomal phosphoprotein P0 of Neospora caninum as a potential common vaccine candidate for the control of both neosporosis and toxoplasmosis. Mol. Biochem. Parasitol.153(2), 141–148 (2007).
   PubMed Web of Science ®Google Scholar
• Jongert E, De Craeye S, Dewit J, Huygen K. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Parasite Immunol.29, 445–453 (2007).
   PubMed Web of Science ®Google Scholar
• Igarashi M, Kano F, Tamekuni K et al.Toxoplasma gondii: evaluation of an intranasal vaccine using recombinant proteins against brain cyst formation in BALB/c mice. Exp. Parasitol.118(3), 386–392 (2008).
   PubMed Web of Science ®Google Scholar
• Cuppari F, Sanchez V, Ledesma B et al.Toxoplasma gondii protease inhibitor-1 (TgPI-1) is a novel vaccine candidate against toxoplasmosis. Vaccine26(39), 5040–5045 (2008).
   PubMed Web of Science ®Google Scholar
• Jongert E, Verhelst D, Abady M, Petersen E, Gargano N. Protective Th1 immune responses against chronic toxoplasmosis induced by a protein–protein vaccine combination but not by its DNA–protein counterpart. Vaccine26(41), 5289–5295 (2008).
   PubMed Web of Science ®Google Scholar
• Qu D, Wang S, Cai W, Du A. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice. Vaccine26, 4541–4548 (2008).
   PubMed Web of Science ®Google Scholar